Pharmacological management of treatment-induced insomnia in ADHD.
Kratochvil
Christopher J
CJ
Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68195-5581, USA. ckratoch@unmc.edu
Lake
Marybeth
M
Pliszka
Steven R
SR
Walkup
John T
JT
D000928:Antidepressive Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003000:Clonidine / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008774:Methylphenidate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced* / Q000188:drug therapy*
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D012702:Serotonin Antagonists; D008774:Methylphenidate; D003533:Cyproheptadine; D003000:Clonidine